Immunopathogenesis of cholestatic autoimmune liver diseases.
about
Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.Chronic cholestatic liver diseases.Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis.Characterization of M2 antibodies in asymptomatic Chinese population.
P2860
Immunopathogenesis of cholestatic autoimmune liver diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunopathogenesis of cholestatic autoimmune liver diseases.
@ast
Immunopathogenesis of cholestatic autoimmune liver diseases.
@en
Immunopathogenesis of cholestatic autoimmune liver diseases.
@nl
type
label
Immunopathogenesis of cholestatic autoimmune liver diseases.
@ast
Immunopathogenesis of cholestatic autoimmune liver diseases.
@en
Immunopathogenesis of cholestatic autoimmune liver diseases.
@nl
prefLabel
Immunopathogenesis of cholestatic autoimmune liver diseases.
@ast
Immunopathogenesis of cholestatic autoimmune liver diseases.
@en
Immunopathogenesis of cholestatic autoimmune liver diseases.
@nl
P2093
P2860
P1476
Immunopathogenesis of cholestatic autoimmune liver diseases.
@en
P2093
García-Monzón C
Moreno-Otero R
P2860
P356
10.1046/J.1365-2362.2001.00765.X
P577
2001-01-01T00:00:00Z